跳至主要内容
临床试验/NCT00783185
NCT00783185已完成1 期

Dual Diagnosis Psychosis and Substance Abuse: Short- and Middle-term Changes in Symptomatology After Visiting a Group Education Programme to Reduce Consumption of Cannabis

University of Konstanz2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2006年1月1日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
50
试验地点
2
主要终点
PANSS Positive and Negative Symptom Scale

研究概览

简要总结

Intention of the study is to examine, if the symptomatology of dual diagnosis patients is less severe after a special indication training for reduction of cannabis consumption in comparison to unspecified trainings.

Point of interest is psychopathology and consumerism.

详细描述

Dual diagnosis patients (psychosis and cannabis abuse) account for more clinical admissions than single diagnosis patients.

Cannabis misuse is a known risk factor for recurrence of psychosis.

A specified intervention on the basis of a manual for schizophrenic substance abusers is administered to inpatients in a specialized unit for young schizophrenic patients in a psychiatric hospital.

The control group, same indication (psychotic disorder and cannabis misuse) receives social competence training (specified for schizophrenic patients as well).

Admission to groups is randomly.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of schizophrenia and disorders with psychotic features
  • Misuse of cannabis during 12 months preceding admission to hospital

排除标准

  • Not able to attend training twice a week for 45 minutes (concentration, attention, psychotic symptoms, agitation)
  • Discharge from hospital before completion of training

结局指标

主要结局

PANSS Positive and Negative Symptom Scale

时间窗: post intervention, six months follow-up

次要结局

  • Urinstatus for cannabinoids(weekly during and post intervention, follow-up)

研究者

发起方
University of Konstanz
申办方类型
Other

研究点 (2)

Loading locations...

相似试验